Download presentation
Presentation is loading. Please wait.
Published byAnn-Sofie Nilsson Modified over 5 years ago
1
The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study
Michael Davidson, MD, Michael Stevenson, RPh, PhD, Andrew Hsieh, PharmD, Zahid Ahmad, MD, Jeanine Roeters van Lennep, MD, PhD, Caroline Crowson, MEM, Joseph L. Witztum, MD Journal of Clinical Lipidology Volume 12, Issue 4, Pages e2 (July 2018) DOI: /j.jacl Copyright © 2018 National Lipid Association Terms and Conditions
2
Figure 1 Physical symptoms at their worst or most severe. For each symptom selected, patients indicated symptom severity and frequency. Severity was recorded on a Likert scale (range, 1–7; 1 = very mild, 7 = very severe). Frequency was recorded by selection from the following options: multiple times per day, daily, every other day, twice a week, once a week, or every other week. Sphere size in the chart is proportional to the percentage of patients who selected each symptom. Journal of Clinical Lipidology , e2DOI: ( /j.jacl ) Copyright © 2018 National Lipid Association Terms and Conditions
3
Figure 2 Emotional symptoms at their worst or most severe. For each symptom selected, patients indicated symptom severity and frequency. Severity was recorded on a Likert scale (range, 1–7; 1 = very mild, 7 = very severe). Frequency was recorded by selection from the following options: multiple times per day, daily, every other day, twice a week, once a week, or every other week. Sphere size in the chart is proportional to the percentage of patients who selected each symptom. Journal of Clinical Lipidology , e2DOI: ( /j.jacl ) Copyright © 2018 National Lipid Association Terms and Conditions
4
Figure 3 Cognitive symptoms at their worst or most severe. For each symptom selected, patients indicated symptom severity and frequency. Severity was recorded on a Likert scale (range, 1–7; 1 = very mild, 7 = very severe). Frequency was recorded by selection from the following options: multiple times per day, daily, every other day, twice a week, once a week, or every other week. Sphere size in the chart is proportional to the percentage of patients who selected each symptom. Journal of Clinical Lipidology , e2DOI: ( /j.jacl ) Copyright © 2018 National Lipid Association Terms and Conditions
5
Figure 4 Number of acute pancreatitis episodes experienced by patients with FCS, who reported acute pancreatitis as a comorbidity. (A) Past 12 months. (B) Lifetime. Journal of Clinical Lipidology , e2DOI: ( /j.jacl ) Copyright © 2018 National Lipid Association Terms and Conditions
6
Figure 5 Management strategies used by patients with FCS. Response percentages may total >100% because respondents may use >1 strategy. Journal of Clinical Lipidology , e2DOI: ( /j.jacl ) Copyright © 2018 National Lipid Association Terms and Conditions
7
Figure 6 Overall interference of FCS with patients' life.
Journal of Clinical Lipidology , e2DOI: ( /j.jacl ) Copyright © 2018 National Lipid Association Terms and Conditions
8
Figure 7 Impact of FCS on social relationships and activities.
Journal of Clinical Lipidology , e2DOI: ( /j.jacl ) Copyright © 2018 National Lipid Association Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.